WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of ...

In a challenging market environment, shares of Eliem Therapeutics, Inc. (CLYM) have reached a 52-week low, dipping to $1.5. According to InvestingPro data, the company maintains a strong financial ...

在充满挑战的市场环境下，Eliem Therapeutics, Inc. (CLYM)的股价已触及52周新低，跌至1.5美元。根据InvestingPro数据显示，该公司保持着稳健的财务状况，流动比率为57.7，资产负债表上现金多于债务。这家专注于开发神经系统疾病治疗方案的生物制药公司，其股价在过去一年中已从高位大幅回落。投资者目睹了公司市值的显著下降，过去六个月股价暴跌74%，目前市值为1.04 ...

Research analysts at Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Climb Bio in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

WELLESLEY, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

WELLESLEY, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate at the Oppenheimer 35 th Annual Healthcare ...

How many Broadway shows has Kevin Kline been in? Kevin Kline has appeared on Broadway in 19 shows. How many West End shows has Kevin Kline been in? Kevin Kline has not appeared in the West End ...

Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) traded down 0.5% during trading on Wednesday .The company traded as low as $1.78 and last traded at $1.87. 260,564 shares changed hands during mid ...